Source comparison
MOTS-c Legal 2026 Status: Product Type Comparison
Research-Grade MOTS-c (Lyophilized) Investigational new drug (IND). FDA-registered synthesis, HPLC verified Legal for institutional research with IRB approval and CoA documentation Low if sold with proper labeling; moderate if sold to individuals without verif
This comparison does not assign a generated winner or score.
- Research-Grade MOTS-c (Lyophilized)
- Investigational new drug (IND). FDA-registered synthesis, HPLC verified
- Legal for institutional research with IRB approval and CoA documentation
- Low if sold with proper labeling; moderate if sold to individuals without verification
- This is the only legally defensible MOTS-c product format in 2026. Purity and documentation are verifiable and compliant
- Compounded MOTS-c (503B Pharmacy)
- Unapproved drug product compounded under state pharmacy board oversight
- Legal only with valid prescription from licensed prescriber; not available over-the-counter
- Moderate. Compounded peptides face scrutiny when prescribed off-label without clinical justification
- Prescription requirement limits access; availability depends on prescriber willingness to write for investigational peptides
- MOTS-c Supplements (Oral Capsules)
- Misbranded drug or adulterated supplement under FD&C Act Section 201(g)(1)
- Illegal to market or sell with therapeutic claims; subject to FDA seizure and warning letters
- High. FDA has issued multiple enforcement actions against peptide supplements since 2024
- Oral bioavailability of peptides is negligible due to gastric degradation; these products are scientifically and legally indefensible
- MOTS-c from Unregistered Suppliers
- Unapproved drug sold without FDA facility registration or third-party purity verification
- Illegal under FD&C Act; no legal purchase context for research or personal use
- Very high. Shipments subject to customs seizure; suppliers face federal enforcement
- No CoA, no traceability, no compliance pathway. Avoid entirely